Merck emerged victorious in the first federal lawsuit for Vioxx but the drug company faces an uphill battle as thousands of cases remain pending.

Whitehouse Station, N.J.-Merck logged its second Vioxx win after a New Orleans jury rejected a claim by the widow of Richard Irvin, a Florida man who died in 2001. Evelyn Irvin-Plunkett alleged her husband’s use of Vioxx led, in part, to his fatal heart attack.

The Irvin-Plunkett case involved a plaintiff who had multiple long-standing cardiovascular risk factors and was a short-term user of Vioxx (less than one month), according to John Boris of Bear Stearns in a note issued to clients today.

“The legal hurdle will increase for Merck going forward as upcoming cases involve Long-Term (LT) Vioxx use cases,” the pharmaceutical analyst said.

The next trial for Merck is set for Feb. 27 and will take place in New Jersey Superior Court. The consolidated case involves two patients who each used Vioxx for 25 months and 49 months, respectively.

At the end of 2005, Merck’s legal reserves totaled approximately $685 million, Boris noted, which is expected to cover the company’s litigation costs through 2007.

The Bear Stearns analyst maintained a “peer perform” rating on Merck. “We believe the downside risk from current levels is limited anchored by Merck offering an attractive 4.4% dividend.”



We're here to help!

We live by our creed of "helping those who need it most" and have helped thousands of clients get the justice they desperately needed and deserved. If you feel you have a case or just have questions please contact us for a free consultation. There is no risk and no fees unless we win for you.

Fields marked    may be required for submission.
  1. I'm an attorney

Merck to pay $830 million to settle investors’ Vioxx...

Merck announced Friday it will pay $830 million to settle investor complaints accusing it of committing...

Merck to pay nearly $1 billion for illegal marketing...

American pharmaceutical company Merck, Sharp & Dohme has agreed to pay $950 million to resolve criminal...

Merck paying more than 3,100 vioxx death claims

Merck & Co. is paying claims by the families of more than 3,100 users of its Vioxx painkiller who...

Settlement limits insurers' claims in Vioxx deal

TRENTON, N.J. (AP) -- Former Vioxx users getting part of a $4.85 billion settlement ending most personal...

Persistence pays in Vioxx litigation

Plaintiffs get close to $5B, but Merck could have done a lot worse. Attorneys who spent nearly one year...

Vioxx settlement payments to begin in August

Merck & Co., manufacturer of Vioxx, announced it will make the first payment of $500 million on Aug....

Impressed with the Beasley Allen staff

I am very impressed with the Beasley Allen staff. They were very courteous and patiently explained the aspects of my claim in a way I could understand. If I ever have any need of an attorney in the future I will turn to Beasley Allen.

—Philip